Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.
about
What is the optimum antibiotic prophylaxis in patients undergoing implantation of a left ventricular assist device?Technique for minimizing and treating driveline infections.Left ventricular assist devices as a bridge to cardiac transplantation.Clinical outcomes after continuous-flow left ventricular assist device: a systematic reviewLeft Ventricular Assist Device Salvage with Omental Flap.Medical management of patients with continuous-flow left ventricular assist devices.Trends in the use and outcomes of ventricular assist devices among medicare beneficiaries, 2006 through 2011.HeartWare and HeartMate II left ventricular assist devices as bridge to transplantation: a comparative analysis.Successful perioperative management of a patient with the left ventricular assist device for brain tumor resection: case report and review of the literature.Disseminated Streptococcus pneumoniae infection involving a ventricular assist deviceShort and long term outcomes of 200 patients supported by continuous-flow left ventricular assist devices.Multidrug-Resistant Organism Infections in Patients with Left Ventricular Assist Devices.A Case of Leukocytoclastic Vasculitis Caused by Listeria monocytogenes Bacteremia.The Importance of the Management of Infectious Complications for Patients with Left Ventricular Assist DeviceClinical manifestations and management of left ventricular assist device-associated infections.New Treatment for Percutaneous Sites in Patients with a Ventricular Assist Device: Nihon University Crystal Violet Method.The Role of Computed Tomography in Predicting Left Ventricular Assist Device Infectious Complications.Left ventricular assist device-related infections: past, present and future.Mechanical circulatory support: devices, outcomes and complications.Ventricular assist device infections.Impact of adverse events on ventricular assist device outcomes.Current concepts in the diagnosis and management of left ventricular assist device infections.HeartWare miniaturized intrapericardial ventricular assist device: advantages and adverse events in comparison to contemporary devices.Current management of left ventricular assist device erosion.Left ventricular assist device exchange for persistent infection: a case series and review of the literature.State of the art of mechanical circulatory support.Evaluation of fever and infections in cardiac surgery patients.Role of gallium SPECT-CT in the diagnosis of left ventricular assist device infections.Necrotizing pulmonary aspergillosis and ventricular assist device infection: case report and review of literature.Current status of mechanical circulatory support for treatment of advanced end-stage heart failure: successes, shortcomings and needs.Case report: atypical fungal obstruction of the left ventricular assist device outflow cannula.Complications, Risk Factors, and Staffing Patterns for Noncardiac Surgery in Patients with Left Ventricular Assist Devices.Variability in infection control measures for the percutaneous lead among programs implanting long-term ventricular assist devices in the United States.Cardiac replacement therapies: outcomes and costs for heart transplantation versus circulatory assist.Fever and Cardiac Arrest in a Patient With a Left Ventricular Assist Device.The value of fluorine-18 deoxyglucose positron emission tomography scans in patients with ventricular assist device specific infections†.Reduction of INCOR® driveline infection rate with silicone at the driveline exit site.Correlation between driveline features and driveline infection in left ventricular assist device selection.Treatment of Infected Cardiac Implantable Electronic Devices.Topical Polymyxin-Trimethoprim Prophylaxis May Decrease the Incidence of Driveline Infections in Patients With Continuous-Flow Left Ventricular Assist Devices.
P2860
Q26853217-0FAE909A-F92C-4026-9C1F-C733CA7F34F1Q26865692-3B705ACB-84A9-43B8-BBE5-E610CEEDC4A9Q26999337-DB5505DD-88D6-4B63-BC93-89BCB609BDB8Q30601099-8A85803E-270C-4C14-97D0-41229F097259Q33601512-09DD9E77-9333-4CD6-A78F-33F8840057B6Q34152572-FEC9321F-7C9F-4555-BB34-858B43CEEC64Q34373693-13A09CB3-A607-40D5-887E-4E02A7950335Q35029983-CDDC23BD-A20C-4C62-9DE0-61C4BEE66297Q35226684-86637C6D-9184-438C-9B0E-49CADEAF3BB5Q35930589-D7A9D04F-6585-487D-80D3-D13D3C655369Q36321056-B52B8AC6-300F-43C8-913B-BB2F30D61EA0Q36334445-538D8548-4A9C-4BDD-90F4-9254A74BEB07Q36995047-ABE63E0C-5FD8-44DB-867C-A3D096612B92Q37081692-A86DF442-5091-47CE-8B3C-E0E8F7E9F938Q37247231-4C88FC0F-B320-4CA8-849A-AEB257288445Q37302779-BDD23FE5-178E-44A3-BBF4-A02EF81066C0Q37390595-A3F9C555-C42F-462D-83A0-B4535CB4A4A6Q37949423-08BBEF26-0733-4510-BB9C-60930585D938Q37991198-D6111689-BB2B-49E5-994E-52A09D579960Q38007865-B1A8C6C4-EB69-4723-A624-EA1D67157F22Q38073665-2EBEC7EF-6BCD-4D92-B820-F714FD807666Q38081496-FEBCB271-B323-4984-B146-9B94253A460CQ38124883-C9842094-2165-42EF-AE1F-AF028AD8AD1CQ38137218-2CAE4A4D-15B0-46AE-A7DF-61DEE262B982Q38202282-D481F1CA-7880-4BFC-A0D4-FF343A122B4EQ38210201-EBE81FC3-B35B-4AF1-AF71-90B07D3DB2ECQ38222719-36A6D439-404D-4AAC-8FBA-5D42CAF2CA15Q38270851-79D2ADCC-5B4A-4B98-BB14-836760EFA77DQ38557212-3BEF29E7-0586-41AD-AE12-A157ED1D53A4Q38870760-DDA149BB-FC78-441B-81C4-9CB94BCB1B16Q38904218-8CF17346-6F2C-46F8-9661-774704C43FDEQ39036332-8E03085E-5A83-4040-AA19-9B5DE0F9652DQ39513183-94517FB9-B1B5-45AA-9DDC-B4FB8058F8EAQ39719220-4A4DC666-34F4-4165-AC73-BF3FA9C88BFCQ40138884-0C2EECBC-6D85-48DD-BF08-77BA2C59676AQ40283817-A760E39D-9730-4F0B-B403-B54992D47897Q40517323-DD8C22D7-F7D9-4B52-9086-965EF2F41094Q40603345-BC79D5E2-08D6-4111-81F1-1A04A3159463Q40685075-1464008F-4F1A-4ED0-A5FD-155CB823A797Q40706120-44C6FD87-8BED-4CA4-A941-B1CCA898B560
P2860
Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Infectious complications in pa ...... es in the continuous-flow era.
@en
Infectious complications in pa ...... es in the continuous-flow era.
@nl
type
label
Infectious complications in pa ...... es in the continuous-flow era.
@en
Infectious complications in pa ...... es in the continuous-flow era.
@nl
prefLabel
Infectious complications in pa ...... es in the continuous-flow era.
@en
Infectious complications in pa ...... es in the continuous-flow era.
@nl
P2093
P1476
Infectious complications in pa ...... es in the continuous-flow era.
@en
P2093
Fardina Malik
Gregory A Ewald
I-Wen Wang
Nader Moazami
Sreekanth Kondareddy
Veli K Topkara
P304
P356
10.1016/J.ATHORACSUR.2010.04.093
P407
P577
2010-10-01T00:00:00Z